Evidence map›Paper›PMID 30155860›Full record

SynthesisCardiology journal2020

Pulmonary arterial hypertension in the elderly: Clinical perspectives.

Nicholas Rothbard, Abhinav Agrawal, Conrad Fischer, Arunabh Talwar, Sonu Sahni

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Cardiology journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Management of pulmonary arterial hypertension in patients aged over 65 years.European heart journal supplements : journal of the European Society of Cardiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Nicholas RothbardDepartment of Primary Care, Touro College of Osteopathic Medicine, 230 West 125th Street, Suite 220, 10027 New York, United States.
Abhinav AgrawalDepartment of Pulmonary, Northwell Health System, Critical Care and Sleep Medicine, 410 Lakeville Rd., Suite 107, 11040 New Hyde Park, United States.
Conrad FischerDepartment of Primary Care, Touro College of Osteopathic Medicine, 230 West 125th Street, Suite 220, 10027 New York, United States.
Arunabh TalwarDepartment of Pulmonary, Northwell Health System, Critical Care and Sleep Medicine, 410 Lakeville Rd., Suite 107, 11040 New Hyde Park, United States.
Sonu SahniDepartment of Primary Care, Touro College of Osteopathic Medicine, 230 West 125th Street, Suite 220, 10027 New York, United States. sahni.sonu@gmail.com.
Brookdale University Hospital and Medical Center · USNorthwell Health · USTouro College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary hypertension (PH) is a rare and devastating disease characterized by progressive increases in pulmonary arterial pressure and pulmonary vascular resistance, which eventually leads to right ventric-ular failure and death. Pulmonary arterial hypertension (PAH) (World Health Organization Group I), a subset of PH, and may be idiopathic in nature or associated with other systemic conditions and is thought to most commonly effect women, the majority of whom are of childbearing age. However, PAH in the elderly population is being increasingly diagnosed creating clinical considerations that had once not been considered. Often in an elderly population the diagnosis of PAH may be delayed due to chronic comorbid conditions such as coronary artery disease or other dyspneic conditions. Though survival and clinical outcomes have improved, the elderly population continues to have disproportionately lower survival rates. High clinical suspicion of PAH warrants a complete diagnostic workup with right heart catheterization. Upon diagnosis, PAH specific therapy should be initiated with possible drug interactions in mind. Adjuvant pulmonary rehabilitation should be considered as a conservative measure with definitive results. Finally, psychosomatic aspects of the disease should also be considered in elderly populations.

Indexed as

Conservative TreatmentAgedAged, 80 and overAge FactorsAntihypertensive AgentsArterial PressureComorbidityDrug InteractionsFemaleHumansMalePulmonary Arterial HypertensionPulmonary ArteryRisk AssessmentRisk FactorsTreatment OutcomeAntihypertensive Agentsgeriatric medicinepulmonary arterial hypertensionpulmonary hypertensionpulmonary hypertension in the elderlypulmonary vascular disease

Identifiers

PMID30155860
PMCPMC8016023
OpenAlexW2888092122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.